
United States · Biopharma startup
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
Funding reportedLast round: Series A
Follow NanoMosaic and see its new rounds in your feed.Start following
Funding, as reported
Add your raise, your deck and your story, and put NanoMosaic in front of investors. Or tell us what we have wrong.